Clinical outcome in patients with acute hypertensive hemorrhagic stroke with intravenous fluid versus no intravenous fluid: A randomized controlled study

Institute of Medical Sciences Banaras Hindu University0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•All the patients admitted to our hospital with acute hypertensive hemorrhagic stroke (based on clinical and radiological features) within a period of 72hrs from the onset of symptoms and consenting to be part of the study will be included after screening for inclusion and exclusion criteria.

•1.Not willing to participate in the study or no informed consent.
•2.Those with GCS less than or equal to 8 at admission.
•3.Prepared for or received surgical intervention within 14 days.
•4.Patients with co-morbid conditions like cardiac failure, low ejection fraction ( <40%), renal failure with admission serum creatinine more than 2, fluid overload, acute liver failure, liver cirrhosis, cancer under treatment, fever, or any conditions which require more aggressive hydration or blood or blood component transfusion at the time of admission.
•5.Patients with sepsis, hypotension, DKA, electrolyte disturbances requiring urgent correction, requiring ICU admission or those with critical illness.
•6.Life expectancy or any reasons for follow-up < 3 months.
•7.Those who received fluid from other hospital before reaching our hospital.

发起方